KIMBERLY SPEARS: Open Payments
NPI 1558564138 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$93 in 5 payments from 5 companies in 2025. Trend: 2023 $167 · 2024 $505 · 2025 $93
Food & beverage: $93
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
Products named: INGREZZA, Auvelity, VRAYLAR, COBENFY, FANAPT.
Industry payments across ID — which companies pay providers there.
